MENU
BSEM
AS OF
Feb 3 closing price
Price
$6.50
Change
+$1.90 (+41.30%)
Capitalization
108.97M
61 days until earnings call
Intraday BUY SELL Signals
+Compare
BSEM
Stock ticker: OTC
AS OF
Feb 3 closing price
Price
$6.50
Change
+$1.90 (+41.30%)
Capitalization
108.97M

BSEM BioStem Technologies, Inc. Forecast, Technical & Fundamental Analysis

BioStem Technologies Inc is a regenerative biotechnology company focused on harnessing elements of perinatal tissue and the body’s innate biology to repair or reverse damage caused by a broad range of degenerative diseases... Show more

BSEM
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for BSEM with price predictions
Feb 03, 2026

BSEM's RSI Oscillator recovers from overbought zone

The 10-day RSI Indicator for BSEM moved out of overbought territory on January 28, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 24 instances where the indicator moved out of the overbought zone. In of the 24 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 68 cases where BSEM's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BSEM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

BSEM broke above its upper Bollinger Band on January 27, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on January 21, 2026. You may want to consider a long position or call options on BSEM as a result. In of 105 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for BSEM just turned positive on January 22, 2026. Looking at past instances where BSEM's MACD turned positive, the stock continued to rise in of 54 cases over the following month. The odds of a continued upward trend are .

BSEM moved above its 50-day moving average on January 21, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for BSEM crossed bullishly above the 50-day moving average on January 12, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a +5 3-day Advance, the price is estimated to grow further. Considering data from situations where BSEM advanced for three days, in of 178 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 148 cases where BSEM Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. BSEM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.179) is normal, around the industry mean (27.519). P/E Ratio (7.386) is within average values for comparable stocks, (51.491). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.893). Dividend Yield (0.000) settles around the average of (0.043) among similar stocks. P/S Ratio (0.525) is also within normal values, averaging (331.843).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to slightly better than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BSEM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

View a ticker or compare two or three
BSEM
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

BSEM is expected to report earnings to fall 60.00% to 1 cents per share on April 06

BioStem Technologies, Inc. BSEM Stock Earnings Reports
Q4'25
Est.
$0.02
Q3'25
Missed
by $0.23
Q2'25
Missed
by $1.31
Q1'25
Missed
by $0.24
Q4'24
Beat
by $0.56
The last earnings report on November 13 showed earnings per share of 5 cents, missing the estimate of 28 cents. With 184.46K shares outstanding, the current market capitalization sits at 108.97M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
2836 Center Port Circle
Phone
+1 954 380-8342
Employees
20
Web
https://www.biostemtechnologies.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CBHC26.05N/A
N/A
CBC Holding Company
GUZOF4.40N/A
N/A
Grupo Herdez, S.A.B. DE C.V.
GFLT10.25-0.17
-1.63%
GenFlat Holdings, Inc.
UMGNF23.10-1.20
-4.96%
UNIVERSAL MUSIC GROUP
PNDRY9.88-1.04
-9.52%
Pandora A/S

BSEM and Stocks

Correlation & Price change

A.I.dvisor tells us that BSEM and VTYX have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BSEM and VTYX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BSEM
1D Price
Change %
BSEM100%
+21.04%
VTYX - BSEM
22%
Poorly correlated
-0.07%
ABSI - BSEM
20%
Poorly correlated
+2.32%
AURA - BSEM
20%
Poorly correlated
+1.02%
CELU - BSEM
20%
Poorly correlated
-2.38%
CLVLY - BSEM
11%
Poorly correlated
+1.78%
More